Related Experiment Video
Updated: Jun 24, 2025

A High Output Method to Isolate Cerebral Pericytes from Mouse
Published on: January 14, 2020
The guardian of intracranial vessels: Why the pericyte?
Kuan Cen1, YinFei Huang1, Yu Xie1
1Department of Neurology, Zhongnan Hospital Affiliated to Wuhan University, Wuhan 430000, China.
Insights
Intracranial atherosclerotic stenosis (ICAS) causes ischemic stroke by narrowing brain arteries. Targeting pericytes may offer new treatments for vulnerable plaques and prevent stroke complications.
Area of Science:
- Neuroscience
- Vascular Biology
- Pathology
Background:
- Intracranial atherosclerotic stenosis (ICAS) is a major cause of ischemic stroke (IS), particularly in East Asian populations.
- The mechanisms behind ICAS prevalence variations and plaque stabilization strategies are not fully understood.
- Plaque rupture, bleeding, and thrombosis are key in intracranial artery obstruction.
Purpose of the Study:
- To explore novel therapeutic strategies targeting pericyte function in vulnerable intracranial atherosclerotic plaques.
- To review the role of pericytes in regulating Vasa Vasorum and preventing intraplaque hemorrhage (IPH).
- To discuss pericyte applications in central nervous system (CNS) diseases and regenerative medicine.
Main Methods:
- Review of current literature on ICAS pathogenesis and pericyte biology.
- Analysis of pericyte's role in vascular integrity and hemorrhage control.
- Exploration of therapeutic modulation of pericytes for plaque stabilization.
Main Results:
- Pericytes are critical regulators of Vasa Vasorum and are implicated in preventing intraplaque hemorrhage.
- Modulating pericyte function presents a promising avenue for targeting vulnerable atherosclerotic plaques.
- Pericytes hold potential for treating CNS diseases and in tissue engineering regeneration.
Conclusions:
- Targeting pericyte biological function offers innovative therapeutic strategies for vulnerable intracranial atherosclerotic plaques.
- Pericytes show promise for future applications in regenerative medicine for CNS diseases.
- Further research into pericyte modulation is crucial for advancing ICAS treatment and stroke prevention.
Abstract:
Intracranial atherosclerotic stenosis (ICAS) is a pathological condition characterized by progressive narrowing or complete blockage of intracranial blood vessels caused by plaque formation. This condition leads to reduced blood flow to the brain, resulting in cerebral ischemia and hypoxia. Ischemic stroke (IS) resulting from ICAS poses a significant global public health challenge, especially among East Asian populations. However, the underlying causes of the notable variations in prevalence among diverse populations, as well as the most effective strategies for preventing and treating the rupture and blockage of intracranial plaques, remain incompletely comprehended. Rupture of plaques, bleeding, and thrombosis serve as precipitating factors in the pathogenesis of luminal obstruction in intracranial arteries. Pericytes play a crucial role in the structure and function of blood vessels and face significant challenges in regulating the Vasa Vasorum (VV)and preventing intraplaque hemorrhage (IPH). This review aims to explore innovative therapeutic strategies that target the pathophysiological mechanisms of vulnerable plaques by modulating pericyte biological function. It also discusses the potential applications of pericytes in central nervous system (CNS) diseases and their prospects as a therapeutic intervention in the field of biological tissue engineering regeneration.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
The Blood-brain Barrier
Nervous Tissue: Glial Cells
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial...
Arteries of the Head and Neck
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
Overview of the Vascular System
Structure of Blood Vessels

